Source: Annual Congress 2004 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Martin- Vivaldi, E. Fernandez, B. Hortal, M. Ortega, J. M. Diez, C. Martin, M. C. Contreras, M. Guillamon, G. Jimenez, B. Alcazar (Granada, Spain). Response to maximal cardiopulmonary exercise testing in patients with hepatopulmonary syndrome. Eur Respir J 2004; 24: Suppl. 48, 3469

Member's Comments

No comment yet.

Related content which might interest you: Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome. Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019 Cardiopulmonary and metabolic responses to ramp-incremental exercise in subjects with idiopathic hyperventilation Source: Eur Respir J 2001; 18: Suppl. 33, 356s Year: 2001 Maximal cardiopulmonary exercise testing in children with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Oxygen kinetics during submaximal cardiopulmonary exercise testing (CPET) in adult patients with cystic fibrosis is related to Schwachman score Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Cardiopulmonary exercise testing in patients with severe pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 489s Year: 2001 Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Cardiopulmonary exercise test in the evaluation of patients with unexplained dyspnea Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Cardiopulmonary exercise testing in sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 184s Year: 2003 Oxygen kinetics during submaximal cardiopulmonary exercise testing in adult patients with cystic fibrosis is related to disease severity Source: Eur Respir J 2006; 28: Suppl. 50, 639s Year: 2006 Cardiopulmonary exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 88s Year: 2003 Physiological responses to cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Exertional dyspnoea in cardiorespiratory disorders: the clinical use of cardiopulmonary exercise testing Source: Eur Respir Rev 2016; 25: 227-229 Year: 2016 Cardiopulmonary exercise testing in risk stratification of patients with PAH associated with congenital heart disease and Eisenmenger syndrome Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing Year: 2011 Oxygen kinetics during submaximal cardiopulmonary exercise testing (CPET) in adult patients with cystic fibrosis is related to maximal exercise breathing pattern Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Cardiopulmonary response during whole-body vibration training in patients with severe COPD Source: ERJ Open Res, 3 (1) 00101-2016; 10.1183/23120541.00101-2016 Year: 2017 Chronotropic incompetence during maximal cardiopulmonary exercise test in patients with COPD and CHF Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009 Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019